Literature DB >> 3548400

Tumor markers in the human ovary and its neoplasms. A comparative immunohistochemical study.

E J Nouwen, P G Hendrix, S Dauwe, M W Eerdekens, M E De Broe.   

Abstract

The incidence and histologic characteristics of the expression of placental alkaline phosphatase (PLAP) in ovarian tumors was compared with that of five other tumor antigens. Three monoclonal antibodies were used for the specific localization of PLAP. PLAP was present in some sex cord cells of the 13-16-week fetal ovary, probably germ cells. In normal ovaries, all antigens except carcinoembryonic antigen (CEA) were frequently found in inclusion cysts; the germinal epithelium was positive only for cancer antigen 125 (CA 125). The frequency and extent of PLAP expression in nonmucinous carcinomas was higher than observed for CA 19-9 and CEA, but was lower than for CA 125 and human milk fat globule antigen. Serous tumors had the highest PLAP expression, followed by endometrioid and poorly differentiated adenocarcinomas, and some other tumors. PLAP was predominantly membranous; its histologic distribution was in general heterogeneous. Different antibodies to PLAP gave different staining intensities in some tumors, but the staining patterns were always qualitatively identical.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3548400      PMCID: PMC1899567     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  Common epithelial tumours of the ovary--a new look.

Authors:  P Russell
Journal:  Pathology       Date:  1985-10       Impact factor: 5.306

2.  Carcinoembryonic antigen in ovarian epithelial cystadenocarcinomas: the prognostic value of tumor and serial plasma determinations.

Authors:  J R van Nagell; E S Donaldson; E C Gay; R M Sharkey; P Rayburn; D M Goldenberg
Journal:  Cancer       Date:  1978-06       Impact factor: 6.860

3.  Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture.

Authors:  J Taylor-Papadimitriou; J A Peterson; J Arklie; J Burchell; R L Ceriani; W F Bodmer
Journal:  Int J Cancer       Date:  1981-07-15       Impact factor: 7.396

4.  Colorectal carcinoma antigens detected by hybridoma antibodies.

Authors:  H Koprowski; Z Steplewski; K Mitchell; M Herlyn; D Herlyn; P Fuhrer
Journal:  Somatic Cell Genet       Date:  1979-11

5.  Carcinoembryonic antigen (CEA) and other tumor markers in ovarian and cervical cancer.

Authors:  A Malkin; J A Kellen; G M Lickrish; R S Bush
Journal:  Cancer       Date:  1978-09       Impact factor: 6.860

6.  An immunohistochemical study of distribution of carcinoembryonic antigen in epithelial tumours of the ovary.

Authors:  J Heald; C H Buckley; H Fox
Journal:  J Clin Pathol       Date:  1979-09       Impact factor: 3.411

7.  [Azoindoxyl methods for the investigation of hydrolases. IV. Suitability of various diazonium salts (author's transl)].

Authors:  R Gossrau
Journal:  Histochemistry       Date:  1978-09-28

8.  Placental alkaline phosphatase in nonmalignant human cervix.

Authors:  D J Goldstein; L Blasco; H Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

9.  Reactivity of a monoclonal antibody with human ovarian carcinoma.

Authors:  R C Bast; M Feeney; H Lazarus; L M Nadler; R B Colvin; R C Knapp
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

10.  The occurrence of human placental alkaline phosphatase (PLAP) in extracts of normal, benign and malignant tissues of the female genital tract.

Authors:  A van de Voorde; R Serreyn; J de Boever; P de Waele; D Vandekerckhove; W Fiers
Journal:  Tumour Biol       Date:  1985
View more
  18 in total

Review 1.  Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer.

Authors:  Ajay P Singh; Shantibhusan Senapati; Moorthy P Ponnusamy; Maneesh Jain; Subodh M Lele; John S Davis; Steven Remmenga; Surinder K Batra
Journal:  Lancet Oncol       Date:  2008-11       Impact factor: 41.316

2.  Metaplastic changes in cultured human ovarian surface epithelium.

Authors:  A S Wong; P C Leung; S L Maines-Bandiera; N Auersperg
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-10       Impact factor: 2.416

3.  Use of immunohistochemical staining panel for characterisation of ovarian neoplasms.

Authors:  P Ashorn; M Helle; H Helin; R Ashorn; K Krohn
Journal:  J Clin Pathol       Date:  1988-01       Impact factor: 3.411

4.  OC-125 as a diagnostic aid in the cytological evaluation of ascitic cells in patients with ovarian carcinoma.

Authors:  R V Skov; P Bichel
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

5.  Papillary serous cystadenoma of the testis.

Authors:  H Kosmehl; L Langbein; F Kiss
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

6.  Monoclonal antibodies against native ovarian tumor cells: specificity and characterization of the antigen. A preliminary report.

Authors:  L Wasserman; A Neri; B Kaplan; Y Manor; M Galli; B Hardy
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

7.  Heat-stable alkaline phosphatase as a marker for human and monkey type-I pneumocytes.

Authors:  E J Nouwen; N Buyssens; M E De Broe
Journal:  Cell Tissue Res       Date:  1990-05       Impact factor: 5.249

8.  MUC16 expression during embryogenesis, in adult tissues, and ovarian cancer in the mouse.

Authors:  Ying Wang; Dong-Joo Cheon; Zhen Lu; Sheena L Cunningham; Chun-Ming Chen; Robert Z Luo; Deyin Xing; Sandra Orsulic; Robert C Bast; Richard R Behringer
Journal:  Differentiation       Date:  2008-07-02       Impact factor: 3.880

9.  CA19-9, CA125 and CEA in endometrial carcinoma tissue and its relation to hormone receptor content and histological grading.

Authors:  W Neunteufel; C Bieglmayer; G Breitenecker
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

10.  CA125/MUC16 is dispensable for mouse development and reproduction.

Authors:  Dong-Joo Cheon; Ying Wang; Jian Min Deng; Zhen Lu; Lianchun Xiao; Chun-Ming Chen; Robert C Bast; Richard R Behringer
Journal:  PLoS One       Date:  2009-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.